Annual Operating Profit:
-$81.11M+$62.20M(+43.40%)Summary
- As of today, GLUE annual operating income is -$81.11 million, with the most recent change of +$62.20 million (+43.40%) on December 31, 2024.
- During the last 3 years, GLUE annual operating profit has fallen by -$8.23 million (-11.29%).
- GLUE annual operating profit is now -914.66% below its all-time high of -$7.99 million, reached on December 31, 2019.
Performance
GLUE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$32.98M-$17.42M(-112.00%)Summary
- As of today, GLUE quarterly operating income is -$32.98 million, with the most recent change of -$17.42 million (-112.00%) on September 30, 2025.
- Over the past year, GLUE quarterly operating profit has dropped by -$6.45 million (-24.31%).
- GLUE quarterly operating profit is now -174.88% below its all-time high of $44.04 million, reached on March 31, 2025.
Performance
GLUE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
$8.51M-$6.45M(-43.10%)Summary
- As of today, GLUE TTM operating income is $8.51 million, with the most recent change of -$6.45 million (-43.10%) on September 30, 2025.
- Over the past year, GLUE TTM operating profit has increased by +$137.49 million (+106.60%).
- GLUE TTM operating profit is now -43.10% below its all-time high of $14.96 million, reached on June 30, 2025.
Performance
GLUE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
GLUE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +43.4% | -24.3% | +106.6% |
| 3Y3 Years | -11.3% | -16.3% | +108.2% |
| 5Y5 Years | -914.7% | -416.4% | +152.9% |
GLUE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.3% | +43.4% | -174.9% | +11.4% | -43.1% | +105.9% |
| 5Y | 5-Year | -914.7% | +43.4% | -174.9% | +11.4% | -43.1% | +105.9% |
| All-Time | All-Time | -914.7% | +43.4% | -174.9% | +11.4% | -43.1% | +105.9% |
GLUE Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$32.98M(-112.0%) | $8.51M(-43.1%) |
| Jun 2025 | - | -$15.55M(-135.3%) | $14.96M(+802.6%) |
| Mar 2025 | - | $44.04M(+238.6%) | -$2.13M(+97.4%) |
| Dec 2024 | -$81.11M(+43.4%) | $13.00M(+149.0%) | -$81.11M(+37.1%) |
| Sep 2024 | - | -$26.53M(+18.7%) | -$128.98M(+7.5%) |
| Jun 2024 | - | -$32.64M(+6.6%) | -$139.42M(+3.2%) |
| Mar 2024 | - | -$34.95M(-0.2%) | -$144.00M(-0.5%) |
| Dec 2023 | -$143.31M(-27.5%) | -$34.86M(+5.7%) | -$143.31M(-1.7%) |
| Sep 2023 | - | -$36.97M(+0.7%) | -$140.94M(-6.5%) |
| Jun 2023 | - | -$37.22M(-8.6%) | -$132.33M(-8.2%) |
| Mar 2023 | - | -$34.26M(-5.4%) | -$122.34M(-8.9%) |
| Dec 2022 | -$112.38M | -$32.49M(-14.6%) | -$112.38M(-8.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$28.36M(-4.2%) | -$103.28M(-9.0%) |
| Jun 2022 | - | -$27.23M(-12.1%) | -$94.79M(-10.6%) |
| Mar 2022 | - | -$24.30M(-3.9%) | -$85.68M(-17.6%) |
| Dec 2021 | -$72.88M(-160.2%) | -$23.39M(-17.7%) | -$72.88M(-47.3%) |
| Sep 2021 | - | -$19.87M(-9.6%) | -$49.49M(-37.4%) |
| Jun 2021 | - | -$18.12M(-57.5%) | -$36.01M(-54.7%) |
| Mar 2021 | - | -$11.50M(-80.1%) | -$23.29M(-44.9%) |
| Dec 2020 | -$28.01M(-250.4%) | - | - |
| Sep 2020 | - | -$6.39M(-18.3%) | -$16.07M(-65.9%) |
| Jun 2020 | - | -$5.40M(-25.7%) | -$9.69M(-125.7%) |
| Mar 2020 | - | -$4.29M | -$4.29M |
| Dec 2019 | -$7.99M | - | - |
FAQ
- What is Monte Rosa Therapeutics, Inc. annual operating income?
- What is the all-time high annual operating profit for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. annual operating profit year-on-year change?
- What is Monte Rosa Therapeutics, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. quarterly operating profit year-on-year change?
- What is Monte Rosa Therapeutics, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Monte Rosa Therapeutics, Inc.?
- What is Monte Rosa Therapeutics, Inc. TTM operating profit year-on-year change?
What is Monte Rosa Therapeutics, Inc. annual operating income?
The current annual operating profit of GLUE is -$81.11M
What is the all-time high annual operating profit for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high annual operating income is -$7.99M
What is Monte Rosa Therapeutics, Inc. annual operating profit year-on-year change?
Over the past year, GLUE annual operating income has changed by +$62.20M (+43.40%)
What is Monte Rosa Therapeutics, Inc. quarterly operating income?
The current quarterly operating profit of GLUE is -$32.98M
What is the all-time high quarterly operating profit for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high quarterly operating income is $44.04M
What is Monte Rosa Therapeutics, Inc. quarterly operating profit year-on-year change?
Over the past year, GLUE quarterly operating income has changed by -$6.45M (-24.31%)
What is Monte Rosa Therapeutics, Inc. TTM operating income?
The current TTM operating profit of GLUE is $8.51M
What is the all-time high TTM operating profit for Monte Rosa Therapeutics, Inc.?
Monte Rosa Therapeutics, Inc. all-time high TTM operating income is $14.96M
What is Monte Rosa Therapeutics, Inc. TTM operating profit year-on-year change?
Over the past year, GLUE TTM operating income has changed by +$137.49M (+106.60%)